microarray-based 24-at testing platform (BlueGnome Limited)
Structured Review
Microarray Based 24 At Testing Platform, supplied by BlueGnome Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+assay+platform/microarray+based+24+at+testing+platform/pm25516085-55-9-14
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: First systematic experience of preimplantation genetic diagnosis for single-gene disorders, and/or preimplantation human leukocyte antigen typing, combined with 24-chromosome aneuploidy testing. Article Snippet: Objective: To study the feasibility, accuracy, and reproductive outcome of 24-chromosome aneuploidy testing (24-AT), combined with preimplantation genetic diagnosis (PGD) for single-gene disorders (SGDs) or human leukocyte antigen (HLA) typing in the same biopsy sample.. Design: Retrospective study.. Setting: Preimplantation genetic diagnosis center. |

![The box extends from the 25th to 75th percentiles, with the horizontal line in the box representing the median; whiskers represent the lowest and highest datum. ( A ) Normalized probe intensity data from <t>microarray</t> experiments. ( B ) Normalized RT-qPCR measurements, expressed as 1/[Δ(C t )] such that increased values correspond to increased gene expression.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_7116/pmc03797116/pmc03797116__pone.0077340.g006.jpg)

